Merit Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Merit Medical Systems (MMSI).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

10Buy

1Hold

Consensus RatingOutperform# Analysts11Avg. Consensus PT$98Upside to Avg. PT+14.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	Needham	Mike Matson	Maintained	Buy	$101
Aug 13, 2026	B of A Securities	Craig Bijou	PT Raise	Neutral	$92→$97
Aug 11, 2026	BTIG	Sam Eiber	Maintained	Buy	$105
Aug 3, 2026	Canaccord Genuity	Jon Young	PT Raise	Buy	$85→$94
Jul 31, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$77→$95
Jul 31, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$96→$106
Jul 31, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Equal-Weight	$74→$83
Jul 31, 2026	Needham	Mike Matson	PT Raise	Buy	$90→$101
Jul 31, 2026	BTIG	Sam Eiber	PT Raise	Buy	$100→$105
May 1, 2026	Canaccord Genuity	Jon Young	PT Cut	Buy	$90→$85
May 1, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$95→$77
May 1, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$78→$74
May 1, 2026	Needham	Mike Matson	PT Cut	Buy	$101→$90
Apr 20, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$109→$107
Apr 17, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$106→$96
Apr 7, 2026	Canaccord Genuity	Jon Young	PT Cut	Buy	$99→$90
Apr 1, 2026	Needham	Mike Matson	Maintained	Buy	$101
Feb 26, 2026	Wells Fargo	Larry Biegelsen	Downgrade	Overweight→Equal-Weight	$95→$78
Feb 25, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$106→$109
Feb 25, 2026	Needham	Mike Matson	PT Cut	Buy	$108→$101

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target

Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.

Benzinga Newsdesk

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.

Avi Kapoor

PRO
B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97

B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price target from $92 to $97.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target

BTIG analyst Sam Eiber reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $105 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $94.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $77 to $95.

Benzinga Newsdesk

Merit Medical Systems Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Merit Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

PRO
B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97

PRO
BTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target

PRO
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94

PRO
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

People Also Watch

People Also Watch

Merit Medical Systems Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Merit Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRONeedham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

PROB of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97

PROBTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target

PROCanaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94

PROJP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

People Also Watch

People Also Watch

PRO
Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target

PRO
B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97

PRO
BTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target

PRO
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94

PRO
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95